This website is intended for healthcare professionals only.
PEDIATRIC AND PEDIATRIC-INSPIRED REGIMENS IN
AYA/ADULT PATIENTS WITH ALL: EFFICACY, SAFETY
AND PRACTICAL INSIGHTS – A US PERSPECTIVE
Prof. Dan Douer Division of Hematology, Keck School of Medicine University of Southern California, Los Angeles, CA, USA
This webinar focused on pediatric and pediatric-inspired regimens in AYA/adult patients: Efficacy, safety and practical insights from a US perspective. Data on the intensification of pediatric ALL regimens were presented and the feasibility of treating adults with pediatric regimens.
Key points covered
Pediatric and pediatric-inspired regimens in AYA/adult patients: Efficacy, safety and practical insights – A US perspective
Benefits and limitations of pediatric-inspired regimens
The most common toxicity in adults
Asparaginase-related toxicities are manageable and depend on risk factors
Webinar Replay
Featured Speakers
Professor Dan Douer
Prof. Dan Douer is an attending physician in the Division of Hematology at the Keck School of Medicine of the University of Southern California in Los Angeles, California. In the last 15 years he shifted his focus from acute promyelocytic leukemia to adult acute lymphoblastic leukemia (ALL) and has established himself as one of the pioneers of applying pediatric treatment approaches to adults. He designed one of the first “pediatric-inspired” regimens for adults with newly diagnosed ALL, paving the way for safer asparaginase administration with improved outcomes and establishing the role of asparaginase in adult patients. He is recognized as an international authority and therapy area expert for adult ALL and the clinical use of different asparaginase formulations.
